Transcriptomic datasets from space-flown mice from GeneLab were extensively mined to extract the key genes that cause muscle atrophy in organ muscle tissues such as the thymus, liver, and spleen. Top ...

"I feel like my muscle strength is dropping again." When working with patients on long-term steroid therapy, I encounter this ...

Muscle loss (atrophy) due to inactivity is common after illness, injury, hospitalization or falls, and becomes increasingly frequent with aging. New research published in Advanced Science shows that ...

As adults age, they're more likely to fall, be hospitalized, or develop chronic disease, and muscle disuse increases these risks. The research team wanted to find a therapeutic solution that could ...

The loss of muscle mass, or muscle atrophy, is a relatively common condition in today's aging and increasingly sedentary societies. While the disuse of muscles is the most frequent catalyst for muscle ...

HOUSTON – A newly identified gene, atrogin-1, is involved in muscle loss associated with cancer, diabetes, fasting and kidney disease as well as in the atrophy occurring with disuse, inactivity, and ...

NEWPORT BEACH, Calif., April 28, 2026 (GLOBE NEWSWIRE)-- NorthStrive Biosciences Inc. ("NorthStrive" or the "Company"), a wholly owned subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB) ("PMGC"), today ...

You might not think of diabetes when you think of muscle function. But a common diabetes drug that regulates blood sugar can also prevent muscle atrophy and muscular fibrosis—which can help the ...

Have you ever been asked by a junior colleague, 'Is this muscle weakness due to disuse?' and found yourself unable to answer immediately? Muscle weakness during long-term steroid administration is a ...

Muscle atrophy is a prevalent condition in today's societies, but many of the roles that mitochondria play in the process remain unclear. In a recent study, researchers investigated how muscle atrophy ...

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Filing seeks to extend EL-22 myostatin-engineered ...